OBAM
ASND icon

ODDO BHF Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

ODDO BHF Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.4M Sell
2025
Q4 		$27.7M Buy
2025
Q3 		$23.9M Buy
2025
Q2 		$11M Buy

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ODDO BHF Asset Management's ASND Position: Q1 2026 in Review

ODDO BHF Asset Management reduced its Ascendis Pharma A/S (ASND) stake by 0.99% in Q1 2026, selling an estimated $288K and leaving 128,657 shares worth $29.4M. The position accounts for 1.16% of the portfolio, ranked #20.

ODDO BHF Asset Management first reported a position in ASND in Q2 2025 and has held it in 4 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • ODDO BHF Asset Management held 128,657 shares of Ascendis Pharma A/S worth $29.4M as of Q1 2026.
  • ODDO BHF Asset Management sold 1,284 Ascendis Pharma A/S shares in Q1 2026, an estimated $288K.
  • Ascendis Pharma A/S made up 1.16% of ODDO BHF Asset Management's portfolio in Q1 2026, its #20 holding.
  • ODDO BHF Asset Management first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 4 quarters since.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on ODDO BHF Asset Management's 13F filing for Q1 2026, filed 18 May 2026.